Type species of the genus CLOSTRIDIUM, a gram-positive bacteria in the family Clostridiaceae. It is used as a source of PROBIOTICS.
A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.
Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS.
GLYCEROPHOSPHOLIPIDS in which one of the two acyl chains is attached to glycerol with an ether alkenyl linkage instead of an ester as with the other glycerophospholipids.
A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes (sometimes called antigenic types, or strains) exist, each producing a different botulinum toxin (BOTULINUM TOXINS). The organism and its spores are widely distributed in nature.
A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)
Derivatives of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations.
A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis (ENTEROCOLITIS, PSEUDOMEMBRANOUS) in patients receiving antibiotic therapy.
Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.
Infections with bacteria of the genus CLOSTRIDIUM.
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.
## I'm sorry for any confusion, but "Japan" is not a medical term or concept. It is a country located in Asia, known as Nihon-koku or Nippon-koku in Japanese, and is renowned for its unique culture, advanced technology, and rich history. If you have any questions related to medical topics, I would be happy to help answer them!
Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.

Batch and fed-batch production of butyric acid by clostridium butyricum ZJUCB. (1/22)

The production of butyric acid by Clostridium butyricum ZJUCB at various pH values was investigated. In order to study the effect of pH on cell growth, butyric acid biosynthesis and reducing sugar consumption, different cultivation pH values ranging from 6.0 to 7.5 were evaluated in 5-L bioreactor. In controlled pH batch fermentation, the optimum pH for cell growth and butyric acid production was 6.5 with a cell yield of 3.65 g/L and butyric acid yield of 12.25 g/L. Based on these results, this study then compared batch and fed-batch fermentation of butyric acid production at pH 6.5. Maximum value (16.74 g/L) of butyric acid concentration was obtained in fed-batch fermentation compared to 12.25 g/L in batch fermentation. It was concluded that cultivation under fed-batch fermentation mode could enhance butyric acid production significantly (P<0.01) by C. butyricum ZJUCB.  (+info)

Microbial conversion of glycerol to 1,3-propanediol: physiological comparison of a natural producer, Clostridium butyricum VPI 3266, and an engineered strain, Clostridium acetobutylicum DG1(pSPD5). (2/22)

Clostridium acetobutylicum is not able to grow on glycerol as the sole carbon source since it cannot reoxidize the excess of NADH generated by glycerol catabolism. Nevertheless, when the pSPD5 plasmid, carrying the NADH-consuming 1,3-propanediol pathway from C. butyricum VPI 3266, was introduced into C. acetobutylicum DG1, growth on glycerol was achieved, and 1,3-propanediol was produced. In order to compare the physiological behavior of the recombinant C. acetobutylicum DG1(pSPD5) strain with that of the natural 1,3-propanediol producer C. butyricum VPI 3266, both strains were grown in chemostat cultures with glycerol as the sole carbon source. The same "global behavior" was observed for both strains: 1,3-propanediol was the main fermentation product, and the qH2 flux was very low. However, when looking at key intracellular enzyme levels, significant differences were observed. Firstly, the pathway for glycerol oxidation was different: C. butyricum uses a glycerol dehydrogenase and a dihydroxyacetone kinase, while C. acetobutylicum uses a glycerol kinase and a glycerol-3-phosphate dehydrogenase. Secondly, the electron flow is differentially regulated: (i) in C. butyricum VPI 3266, the in vitro hydrogenase activity is 10-fold lower than that in C. acetobutylicum DG1(pSPD5), and (ii) while the ferredoxin-NAD+ reductase activity is high and the NADH-ferredoxin reductase activity is low in C. acetobutylicum DG1(pSPD5), the reverse is observed for C. butyricum VPI 3266. Thirdly, lactate dehydrogenase activity is only detected in the C. acetobutylicum DG1(pSPD5) culture, explaining why this microorganism produces lactate.  (+info)

Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. (3/22)

AIM: To investigate the effect of probiotic bacterium, Clostridium butyricum MIYAIRI 588 strain (CBM) on the changes of the fecal flora in Helicobacter pylori (H. pylori) treatment. METHODS: Thirty-five patients with gastric or duodenal ulcers positive for H. pylori were randomized either to 1 wk amoxicillin, clarithromycin, lansoprazole (Group 1) or to the same regimen supplemented with CBM 7 d ahead of the triple therapy (Group 2). Stool samples were collected before and 2, 4, 7, 15, and 22 d after the starting eradication therapy, and were examined intestinal flora. Patients were required to keep a diary record of their condition. RESULTS: Obligate anaerobes decreased significantly on d 2, 4, 8 and 15 in Group 1. On the other hand, they did not decrease significantly in Group 2. The Escherichia coli was dominant bacterium in Enterobacteriaceae, but that was replaced by other species such as Klebsiella and Enterobacter after eradication in Group 1. The change was suppressed in Group 2. Abdominal symptoms were less frequent in Group 2 than in Group 1. CONCLUSION: The combined use of CBM reduced the changes in the intestinal flora and decreased the incidence of gastrointestinal side effects.  (+info)

Effects of dietary supplementation with clostridium butyricum on the growth performance and humoral immune response in Miichthys miiuy. (4/22)

The effects of dietary supplementation with Clostridium butyricum on growth performance and humoral immune response in Miichthys miiuy were evaluated. One hundred and fifty Miichthys miiuy weighing approximately 200-260 g were divided into five groups and reared in 15 tanks with closed circuiting culture system. The animals were fed 5 diets: basal diet only (control) or supplemented of the basal diet with C. butyricum at doses of 10(3) (CB1), 10(5) (CB2), 10(7) (CB3) or 10(9) (CB4) CFU/g. Compared with the control, the serum phenoloxidase activity was significantly increased by the supplementation (P<0.05), acid phosphatases activity was increased significantly (P<0.05) at the doses of 10(9) CFU/g. Serum lysozyme activity peaked at dose of 10(7) CFU/g and in the skin mucus at dose of 10(9) CFU/g. Immunoglobulin M level in the serum and skin mucus was increased except at dose of 10(3) CFU/g (P<0.05). The growth at the dose of 10(9) CFU/g was higher than that of the control (P<0.05). It is concluded that supplementation of C. butyricum can mediate the humoral immune responses and improve the growth performance in Miichthys miiuy.  (+info)

Clostridium butyricum sepsis in an injection drug user with an indwelling central venous catheter. (5/22)

 (+info)

Ability of Lactobacillus fermentum to overcome host alpha-galactosidase deficiency, as evidenced by reduction of hydrogen excretion in rats consuming soya alpha-galacto-oligosaccharides. (6/22)

 (+info)

Effects of active egg white product/ Clostridium butyricum Miyairi 588 additive on peripheral leukocyte populations in periparturient dairy cows. (7/22)

The leukocyte populations of periparturient dairy cows were analyzed after administration of active egg white/Clostridium butyricum Miyairi additive. Sixty-eight Holstein milking cows were divided into 3 groups. Group A was administered active egg white product (AEWP)/Clostridium butyricum Miyairi 588 (Miyairi 588) additive (n=23). Group B was administered Miyairi 588 only (n=23), and Group C was the control group (n=22). The challenged groups were administered 100 g of AEWP + Miyairi 588, or Miyairi 588 alone, daily for 60 days from 1 month before until 1 month after paturition. Blood samples were collected from all groups three times (1 month before, 1 week after and 1 month after parturition) for analysis of the peripheral leukocyte population. The results showed significantly higher numbers of CD4+ cells in Group A compared with Group C 1 week after paturition. AEWP/Miyairi 588 additive may enhance the number of CD4+ T cells in periparturient dairy cows.  (+info)

Microbial conversion of glycerol to 1,3-propanediol by an engineered strain of Escherichia coli. (8/22)

 (+info)

'Clostridium butyricum' is a gram-positive, spore-forming, rod-shaped bacterium that is commonly found in the environment, including soil and water. It is also part of the normal gut microbiota in humans and animals. This organism produces butyric acid as one of its main fermentation products, hence the name 'butyricum'.

While 'Clostridium butyricum' can sometimes be associated with human diseases, particularly in individuals with weakened immune systems or underlying gastrointestinal disorders, it is also being investigated for its potential probiotic properties. Some studies suggest that certain strains of this bacterium may help prevent and treat various conditions, such as antibiotic-associated diarrhea, irritable bowel syndrome, and inflammatory bowel disease. However, more research is needed to confirm these findings and establish the safety and efficacy of 'Clostridium butyricum' as a probiotic.

'Clostridium' is a genus of gram-positive, rod-shaped bacteria that are widely distributed in nature, including in soil, water, and the gastrointestinal tracts of animals and humans. Many species of Clostridium are anaerobic, meaning they can grow and reproduce in environments with little or no oxygen. Some species of Clostridium are capable of producing toxins that can cause serious and sometimes life-threatening illnesses in humans and animals.

Some notable species of Clostridium include:

* Clostridium tetani, which causes tetanus (also known as lockjaw)
* Clostridium botulinum, which produces botulinum toxin, the most potent neurotoxin known and the cause of botulism
* Clostridium difficile, which can cause severe diarrhea and colitis, particularly in people who have recently taken antibiotics
* Clostridium perfringens, which can cause food poisoning and gas gangrene.

It is important to note that not all species of Clostridium are harmful, and some are even beneficial, such as those used in the production of certain fermented foods like sauerkraut and natto. However, due to their ability to produce toxins and cause illness, it is important to handle and dispose of materials contaminated with Clostridium species carefully, especially in healthcare settings.

Botulinum toxins are neurotoxic proteins produced by the bacterium Clostridium botulinum and related species. They are the most potent naturally occurring toxins, and are responsible for the paralytic illness known as botulism. There are seven distinct botulinum toxin serotypes (A-G), each of which targets specific proteins in the nervous system, leading to inhibition of neurotransmitter release and subsequent muscle paralysis.

In clinical settings, botulinum toxins have been used for therapeutic purposes due to their ability to cause temporary muscle relaxation. Botulinum toxin type A (Botox) is the most commonly used serotype in medical treatments, including management of dystonias, spasticity, migraines, and certain neurological disorders. Additionally, botulinum toxins are widely employed in aesthetic medicine for reducing wrinkles and fine lines by temporarily paralyzing facial muscles.

It is important to note that while botulinum toxins have therapeutic benefits when used appropriately, they can also pose significant health risks if misused or improperly handled. Proper medical training and supervision are essential for safe and effective utilization of these powerful toxins.

Plasmalogens are a type of complex lipid called glycerophospholipids, which are essential components of cell membranes. They are characterized by having a unique chemical structure that includes a vinyl ether bond at the sn-1 position of the glycerol backbone and an ester bond at the sn-2 position, with the majority of them containing polyunsaturated fatty acids. The headgroup attached to the sn-3 position is typically choline or ethanolamine.

Plasmalogens are abundant in certain tissues, such as the brain, heart, and skeletal muscle. They have been suggested to play important roles in cellular functions, including membrane fluidity, signal transduction, and protection against oxidative stress. Reduced levels of plasmalogens have been associated with various diseases, including neurological disorders, cardiovascular diseases, and aging-related conditions.

'Clostridium botulinum' is a gram-positive, rod-shaped, anaerobic bacteria that produces one or more neurotoxins known as botulinum toxins. These toxins are among the most potent naturally occurring biological poisons and can cause a severe form of food poisoning called botulism in humans and animals. Botulism is characterized by symmetrical descending flaccid paralysis, which can lead to respiratory and cardiovascular failure, and ultimately death if not treated promptly.

The bacteria are widely distributed in nature, particularly in soil, sediments, and the intestinal tracts of some animals. They can form spores that are highly resistant to heat, chemicals, and other environmental stresses, allowing them to survive for long periods in adverse conditions. The spores can germinate and produce vegetative cells and toxins when they encounter favorable conditions, such as anaerobic environments with appropriate nutrients.

Human botulism can occur through three main routes of exposure: foodborne, wound, and infant botulism. Foodborne botulism results from consuming contaminated food containing preformed toxins, while wound botulism occurs when the bacteria infect a wound and produce toxins in situ. Infant botulism is caused by the ingestion of spores that colonize the intestines and produce toxins, mainly affecting infants under one year of age.

Prevention measures include proper food handling, storage, and preparation practices, such as cooking and canning foods at appropriate temperatures and for sufficient durations. Wound care and prompt medical attention are crucial in preventing wound botulism. Vaccines and antitoxins are available for prophylaxis and treatment of botulism in high-risk individuals or in cases of confirmed exposure.

Botulism is a rare but serious condition caused by the toxin produced by the bacterium Clostridium botulinum. The neurotoxin causes muscle paralysis, which can lead to respiratory failure and death if not treated promptly. Botulism can occur in three main forms: foodborne, wound, and infant.

Foodborne botulism is caused by consuming contaminated food, usually home-canned or fermented foods with low acid content. Wound botulism occurs when the bacterium infects a wound and produces toxin in the body. Infant botulism affects babies under one year of age who have ingested spores of the bacterium, which then colonize the intestines and produce toxin.

Symptoms of botulism include double vision, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, muscle weakness, and paralysis that progresses downward from the head to the limbs. Treatment typically involves supportive care such as mechanical ventilation, intensive care unit monitoring, and antitoxin therapy. Prevention measures include proper food handling and canning techniques, prompt wound care, and avoiding consumption of known sources of contaminated food.

Propylene glycol is not a medical term, but rather a chemical compound. Medically, it is classified as a humectant, which means it helps retain moisture. It is used in various pharmaceutical and cosmetic products as a solvent, preservative, and moisturizer. In medical settings, it can be found in topical creams, oral and injectable medications, and intravenous (IV) fluids.

The chemical definition of propylene glycol is:

Propylene glycol (IUPAC name: propan-1,2-diol) is a synthetic organic compound with the formula CH3CH(OH)CH2OH. It is a viscous, colorless, and nearly odorless liquid that is miscible with water, acetone, and chloroform. Propylene glycol is used as an antifreeze when mixed with water, as a solvent in the production of polymers, and as a moisturizer in various pharmaceutical and cosmetic products. It has a sweet taste and is considered generally recognized as safe (GRAS) by the U.S. Food and Drug Administration (FDA) for use as a food additive.

'Clostridium difficile' (also known as 'C. difficile' or 'C. diff') is a type of Gram-positive, spore-forming bacterium that can be found in the environment, including in soil, water, and human and animal feces. It is a common cause of healthcare-associated infections, particularly in individuals who have recently received antibiotics or have other underlying health conditions that weaken their immune system.

C. difficile produces toxins that can cause a range of symptoms, from mild diarrhea to severe colitis (inflammation of the colon) and potentially life-threatening complications such as sepsis and toxic megacolon. The most common toxins produced by C. difficile are called TcdA and TcdB, which damage the lining of the intestine and cause inflammation.

C. difficile infections (CDIs) can be difficult to treat, particularly in severe cases or in patients who have recurrent infections. Treatment typically involves discontinuing any unnecessary antibiotics, if possible, and administering specific antibiotics that are effective against C. difficile, such as metronidazole, vancomycin, or fidaxomicin. In some cases, fecal microbiota transplantation (FMT) may be recommended as a last resort for patients with recurrent or severe CDIs who have not responded to other treatments.

Preventing the spread of C. difficile is critical in healthcare settings, and includes measures such as hand hygiene, contact precautions, environmental cleaning, and antibiotic stewardship programs that promote the appropriate use of antibiotics.

Fermentation is a metabolic process in which an organism converts carbohydrates into alcohol or organic acids using enzymes. In the absence of oxygen, certain bacteria, yeasts, and fungi convert sugars into carbon dioxide, hydrogen, and various end products, such as alcohol, lactic acid, or acetic acid. This process is commonly used in food production, such as in making bread, wine, and beer, as well as in industrial applications for the production of biofuels and chemicals.

Clostridium infections are caused by bacteria of the genus Clostridium, which are gram-positive, rod-shaped, spore-forming, and often anaerobic organisms. These bacteria can be found in various environments, including soil, water, and the human gastrointestinal tract. Some Clostridium species can cause severe and potentially life-threatening infections in humans. Here are some of the most common Clostridium infections with their medical definitions:

1. Clostridioides difficile infection (CDI): An infection caused by the bacterium Clostridioides difficile, previously known as Clostridium difficile. It typically occurs after antibiotic use disrupts the normal gut microbiota, allowing C. difficile to overgrow and produce toxins that cause diarrhea, colitis, and other gastrointestinal symptoms. Severe cases can lead to sepsis, toxic megacolon, or even death.
2. Clostridium tetani infection: Also known as tetanus, this infection is caused by the bacterium Clostridium tetani. The spores of this bacterium are commonly found in soil and animal feces. They can enter the body through wounds, cuts, or punctures, germinate, and produce a potent exotoxin called tetanospasmin. This toxin causes muscle stiffness and spasms, particularly in the neck and jaw (lockjaw), which can lead to difficulty swallowing, breathing, and potentially fatal complications.
3. Clostridium botulinum infection: This infection is caused by the bacterium Clostridium botulinum and results in botulism, a rare but severe paralytic illness. The bacteria produce neurotoxins (botulinum toxins) that affect the nervous system, causing symptoms such as double vision, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, and muscle weakness. In severe cases, botulism can lead to respiratory failure and death.
4. Gas gangrene (Clostridium perfringens infection): A rapidly progressing soft tissue infection caused by Clostridium perfringens or other clostridial species. The bacteria produce potent exotoxins that cause tissue destruction, gas production, and widespread necrosis. Gas gangrene is characterized by severe pain, swelling, discoloration, and a foul-smelling discharge. If left untreated, it can lead to sepsis, multi-organ failure, and death.
5. Clostridioides difficile infection (C. difficile infection): Although not caused by a typical clostridial species, C. difficile is a gram-positive, spore-forming bacterium that can cause severe diarrhea and colitis, particularly in hospitalized patients or those who have recently taken antibiotics. The bacteria produce toxins A and B, which damage the intestinal lining and contribute to inflammation and diarrhea. C. difficile infection can range from mild to life-threatening, with complications such as sepsis, toxic megacolon, and bowel perforation.

Glycerol, also known as glycerine or glycerin, is a simple polyol (a sugar alcohol) with a sweet taste and a thick, syrupy consistency. It is a colorless, odorless, viscous liquid that is slightly soluble in water and freely miscible with ethanol and ether.

In the medical field, glycerol is often used as a medication or supplement. It can be used as a laxative to treat constipation, as a source of calories and energy for people who cannot eat by mouth, and as a way to prevent dehydration in people with certain medical conditions.

Glycerol is also used in the production of various medical products, such as medications, skin care products, and vaccines. It acts as a humectant, which means it helps to keep things moist, and it can also be used as a solvent or preservative.

In addition to its medical uses, glycerol is also widely used in the food industry as a sweetener, thickening agent, and moisture-retaining agent. It is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration (FDA).

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

Peer review in the context of research refers to the evaluation of scientific, academic, or professional work by others working in the same field. The purpose of peer review is to ensure that the research is rigorous, valid, and relevant to the field. In a peer-review process, experts in the relevant field assess the research article, report, or other type of scholarly work for its accuracy, quality, and significance before it is published or presented at a conference.

The peer-review process typically involves several stages:

1. Submission: The author(s) submit their manuscript to a journal, conference, or other publication venue.
2. Assignment: The editor of the publication assigns the manuscript to one or more reviewers who are experts in the field.
3. Review: The reviewers evaluate the manuscript based on criteria such as originality, methodology, data analysis, interpretation of results, and contribution to the field. They provide feedback and recommendations to the editor.
4. Decision: Based on the feedback from the reviewers, the editor makes a decision about whether to accept, reject, or request revisions to the manuscript.
5. Revision: If the manuscript is rejected or requires revisions, the author(s) may have an opportunity to revise and resubmit the manuscript for further consideration.

Peer review is a critical component of the scientific process, as it helps ensure that research is held to high standards of quality and integrity. It also provides a mechanism for identifying and correcting errors or weaknesses in research before it is published or disseminated widely.

I'm sorry for any confusion, but "Japan" is not a medical term. Japan is the name of a country, officially known as Nippon-koku or Nihon-koku in Japanese, and is located in East Asia. It is an island nation in the Pacific Ocean with a population of about 126 million people.

If you have any medical questions or terms that you would like me to define, please let me know!

Pharmaceutical preparations refer to the various forms of medicines that are produced by pharmaceutical companies, which are intended for therapeutic or prophylactic use. These preparations consist of an active ingredient (the drug) combined with excipients (inactive ingredients) in a specific formulation and dosage form.

The active ingredient is the substance that has a therapeutic effect on the body, while the excipients are added to improve the stability, palatability, bioavailability, or administration of the drug. Examples of pharmaceutical preparations include tablets, capsules, solutions, suspensions, emulsions, ointments, creams, and injections.

The production of pharmaceutical preparations involves a series of steps that ensure the quality, safety, and efficacy of the final product. These steps include the selection and testing of raw materials, formulation development, manufacturing, packaging, labeling, and storage. Each step is governed by strict regulations and guidelines to ensure that the final product meets the required standards for use in medical practice.

"Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain". Journal of ... Clostridium butyricum at BacDive (Articles with short description, Short description matches Wikidata, Use dmy dates from May ... Clostridium butyricum is a strictly anaerobic endospore-forming Gram-positive butyric acid-producing bacillus subsisting by ... In this connection it was circa 1880 when a scientist surnamed Prazmowski first assigned a name to Clostridium butyricum. The ...
Some Clostridium spp. Clostridium butyricum produce butyric acid. Proteolytic bacteria hydrolyze proteins by producing ... Thermophilic bacteria are able to thrive in high temperatures above 50 Celsius, including genera Bacillus, Clostridium, ... This group includes bacteria species from the Bacillus, Clostridium, Aeromonas, Pseudomonas and Enterobacter genera. ... This group includes bacteria species from the Micrococcus, Staphylococcus, Bacillus, Clostridium, Pseudomonas, Alteromonas, ...
used hydrogen produced by the fermentation of glucose by Clostridium butyricum as the reactant at the anode of a hydrogen and ... "Continuous hydrogen production by immobilized whole cels of Clostridium butyricum". Biochimica et Biophysica Acta (BBA) - ... "Biochemical cells utilizing immobilized cells of Clostridium butyricum". Biotechnology and Bioengineering. 19 (11): 1727-1733. ...
Mixtures of Clostridium species, such as Clostridium beijerinckii, Clostridium butyricum, and species from other genera have ... Clostridium butyricum MIYAIRI 588 strain is marketed in Japan, Korea, and China for Clostridium difficile prophylaxis due to ... Clostridium butyricum converts glycerol to 1,3-propanediol. Genes from Clostridium thermocellum have been inserted into ... Lawson, PA; Rainey, FA (February 2016). "Proposal to restrict the genus Clostridium Prazmowski to Clostridium butyricum and ...
"Effect of glucose on glycerol metabolism by Clostridium butyricum". Journal of Applied Microbiology. 84 (4): 515-522. doi: ... Similar to Clostridium acetobutylicum, Clostridium pasteurianum also has the ability to switch from acid to solvent production ... Initially named Clostridium pastorianum by Winogradsky, its name was later changed to the current spelling. Clostridium ... Clostridium pasteurianum (previously known as Clostridium pastorianum) is a bacterium discovered in 1890 by the Russian ...
Lawson PA, Rainey FA (Feb 2016). "Proposal to restrict the genus Clostridium Prazmowski to Clostridium butyricum and related ... and the creation of the illegitimate combinations Clostridium maximum (Lindner 1888) Lawson and Rainey 2016 and Clostridium ... It has been proposed to be renamed to Clostridium ventriculi in 2016, but ultimately retained its name due to the genus name of ... Willems A, Collins MD (Jul 1994). "Phylogenetic placement of Sarcina ventriculi and Sarcina maxima within group I Clostridium, ...
... as well as some strains of Clostridium butyricum and Clostridium baratii, are the bacteria responsible for producing botulinum ... "Rejection of Clostridium putrificum and conservation of Clostridium botulinum and Clostridium sporogenes-Opinion 69. Judicial ... Austin, J.W. (January 1, 2003). "CLOSTRIDIUM , Occurrence of Clostridium botulinum". CLOSTRIDIUM. Academic Press. pp. 1407-1413 ... A few strains from organisms genetically identified as other Clostridium species have caused human botulism: C. butyricum has ...
... was then identified as the same bacterium which had been discovered by two other scientists and renamed Clostridium butyricum. ... ISBN 978-0-08-057033-4. Bahl, Hubert; Dürre, Peter (2001-10-15). Clostridia: Biotechnology & Medical Applications. John Wiley ...
Salmonella typhimurium C. butyricum C. tetani C. histolyticum 17 and 18 C. beijerinckii 19 C. acetobutylicum C. sporogenes ... Clostridium novyi-NT is an attenuated form of Clostridium novyi that is under investigation as a cancer treatment. It is one of ... Among the various Clostridium strains that have been examined, pathogenic strains have a stronger oncolytic effect than others ... In 2014, researchers found that a modified strain of Clostridium novyi bacteria caused tumor shrinkage without damaging normal ...
In 1913, Martinus Beijerinck repeated Van Leeuwenhoek's experiment and identified Clostridium butyricum as a prominent ... Two examples of obligate anaerobes are Clostridium botulinum and the bacteria which live near hydrothermal vents on the deep- ... "The genome of Clostridium kluyveri , a strict anaerobe with unique metabolic features". Proceedings of the National Academy of ... including Clostridia, Enterobacteriaceae, and Gram-positive cocci. Upcroft P, Upcroft JA (January 2001). "Drug Targets and ...
Botulism toxins are produced by bacteria of the genus Clostridium, namely C. botulinum, C. butyricum, C. baratii and C. ... In 1917, Bacillus botulinus was renamed Clostridium botulinum, as it was decided that term Bacillus should only refer to a ... Botulinum toxin produced by Clostridium botulinum is the cause of botulism. Humans most commonly ingest the toxin from eating ... The two are collectively known as Clostridium neurotoxins and the light chain is classified by MEROPS as family M27. ...
Examples of butyrate-producing species of bacteria: Clostridium butyricum Clostridium kluyveri Clostridium pasteurianum ... used also in industry Clostridium beijerinckii Clostridium tetanomorphum Clostridium aurantibutyricum These bacteria begin with ... Some of these species are: Clostridium acetobutylicum, the most prominent acetone and butanol producer, ... "The Genome of Clostridium kluyveri, a Strict Anaerobe with Unique Metabolic Features". Proceedings of the National Academy of ...
... -Clostridium Clostridium acetobutylicum Clostridium botulinum Clostridium butyricum Clostridium difficile Clostridium ... kluyveri Clostridium novyi Clostridium perfringens Clostridium phytofermentans Clostridium tetani Clostridium thermocellum ... Clostridium botulinum, Burkholderia mallei, Burkholderia pseudomallei, Clostridium perfringens, and Entamoeba histolytica) ...
... butyricum, and from a phylogenetic standpoint should not be included in a newly defined genus Clostridium. This extensive ... The Clostridiaceae are a family of the bacterial class Clostridia, and contain the genus Clostridium. The family Clostridiaceae ... The fact that the species of the genus Clostridium did not form a monophyletic group has been shown in a number of studies in ... The genus Clostridium currently comprises 152 validly described species in nomenclature. However, on the basis of 16S rRNA gene ...
Clostridium butyricum, Desulfuromonas acetoxidans, Geobacter metallireducens, Geobacter sulfurreducens, Rhodoferax ...
Clostridium botulinum Clostridium bovifaecis Clostridium bowmanii Clostridium budayi Clostridium butyricum Clostridium ... "Clostridium autoethanogenum" Clostridium baratii Clostridium beihaiense Clostridium beijerinckii Clostridium diolis Clostridium ... Clostridium aceticum Clostridium acetireducens Clostridium acetobutylicum Clostridium acidisoli Clostridium aciditolerans ... Clostridium aestuarii Clostridium akagii Clostridium algidicarnis Clostridium algifaecis Clostridium algoriphilum Clostridium ...
... butyric acid made by the bacterium Clostridium butyricum, lactic acid made by Lactobacillus and other lactic acid bacteria, and ...
Clostridium botulinum type G MeSH B03.300.390.400.200.180 - Clostridium butyricum MeSH B03.300.390.400.200.200 - Clostridium ... Clostridium botulinum type G MeSH B03.510.415.400.200.180 - Clostridium butyricum MeSH B03.510.415.400.200.200 - Clostridium ... Clostridium symbiosum MeSH B03.300.390.400.200.722 - Clostridium tertium MeSH B03.300.390.400.200.725 - Clostridium tetani MeSH ... Clostridium symbiosum MeSH B03.510.415.400.200.722 - Clostridium tertium MeSH B03.510.415.400.200.725 - Clostridium tetani MeSH ...
Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-World War II Germany ... butyricum, and C. difficile, but this has not been proved. Protein poisoning refers to a different diet-induced phenomenon. " ... Fu, Ying; Alenezi, Tahrir; Sun, Xiaolun (June 2022). "Clostridium perfringens-Induced Necrotic Diseases: An Overview". Immuno. ... is a severe and potentially fatal type of food poisoning caused by a β-toxin of Clostridium perfringens, Type C. It occurs in ...
Clostridium acetobutylicum Clostridium aurantibutyricum Clostridium beijerinckii Clostridium butyricum Clostridium cadaveris ... Clostridium chauvoei Clostridium felsineum Clostridium pasteurianum Clostridium puniceum Clostridium roseum Clostridium ... Some species such as Clostridium beijerinckii, Clostridium puniceum and Clostridium roseum are able to further reduce acetone ... Clostridium saccharoperbutylacetonicum Clostridium tetanomorphum Clostridium thermosaccharolyticum Clostridium tyrobutyricum ...
"Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain". Journal of ... Clostridium butyricum at BacDive (Articles with short description, Short description matches Wikidata, Use dmy dates from May ... Clostridium butyricum is a strictly anaerobic endospore-forming Gram-positive butyric acid-producing bacillus subsisting by ... In this connection it was circa 1880 when a scientist surnamed Prazmowski first assigned a name to Clostridium butyricum. The ...
... Nucleic Acids Res. 2019 Jun 20;47(11):5809- ... and structural characterization of the siDNA-guided DNA-targeting pAgo from the mesophilic bacterium Clostridium butyricum ( ...
Isa K, Oka K, Beauchamp N, Sato M, Wada K, Ohtani K, et al. Safety assessment of the Clostridium butyricum MIYAIRI 588® ... Oka K, McCartney E, Ariyoshi T, Kudo H, Vilá B, de Jong L, et al. In vivo safety evaluation of the Clostridium butyricum ... Tran NT, Li Z, Ma H, Zhang Y, Zheng H, Gong Y, et al. Clostridium butyricum: a promising probiotic confers positive health ... Cassir N, Benamar S, Khalil JB, Croce O, Saint-Faust M, Jacquot A, et al. Clostridium butyricum strains and dysbiosis linked to ...
This includes adding novel feed additives to support gut health at weaning, such as the probiotic Clostridium butyricum. And as ... A good example is Huvepharmas Clostridium butyricum, a well-known probiotic with proven benefits in regard to supporting the ... A total of 64 sows were divided over a control and a C. butyricum group (CB), with piglets being followed up for 21 days after ...
Supplier company of Clostridium Butyricum in Ahmedabad, Gujarat,India ...
Allows to visualize regulon content in the context of metabolic pathways ...
Clostridium Butyricum belongs to the family of bacillus and clostridium, Gram-positive with spore and has strong resistance to ... Clostridium Butyricum RENGTY® Clostridium Butyricum belongs to the family of bacillus and clostridium, Gram-positive with spore ... RENGTY® Clostridium Butyricum belongs to the family of bacillus and clostridium, Gram-positive with spore and has strong ... Clostridium butyrate is sensitive to only a few antibiotics, such as neomycin, vancomycin and tetracycline, and has strong ...
Establishment and evaluation of a method for efficient screening of Clostridium butyricum *Zhi Yi ... Clostridium difficile infection: a comprehensive review. Crit. Rev. Microbiol. 37, 178-187 (2011). ... Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415 (2013). ... Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol. 20, ...
In this study transcriptomic and proteomic analyses of the hydrogen-producing bacterium Clostridium butyricum CWBI 1009 were ... N2 - In this study transcriptomic and proteomic analyses of the hydrogen-producing bacterium Clostridium butyricum CWBI 1009 ... AB - In this study transcriptomic and proteomic analyses of the hydrogen-producing bacterium Clostridium butyricum CWBI 1009 ... abstract = "In this study transcriptomic and proteomic analyses of the hydrogen-producing bacterium Clostridium butyricum CWBI ...
1. Clostridium Butyricum. Unfortunately, there is only one commercial probiotic bacteria strain that I have found that can ... It is called Clostridium Butyricum. But it only produces butyrate and not the other two dominant SCFAs, acetate and propionate ... Clostridium Difficile (C.Diff) - This is the #1 health issue FMT is used for. ...
Why can the compound bacteria based on Clostridium butyricum replace antibiotics in aquaculture?-Henan JBH Biotech Co., Ltd- ... What is the compound bacteria based on Clostridium butyricum?. The compound bacteria based on Clostridium butyricum is a ... Clostridium Butyricum Other Strains Compound Probiotics Aqua Probiotics Environmental Protection Material News Contact ... What is the difference between antibiotics and the compound bacteria based on Clostridium butyricum? ...
Dive into the research topics of Conversion of phenylpyruvate to l-phenylalanine by immobilized Clostridium butyricum-alanine ... Conversion of phenylpyruvate to l-phenylalanine by immobilized Clostridium butyricum-alanine dehydrogenase-Micrococcus luteus ... Conversion of phenylpyruvate to l-phenylalanine by immobilized Clostridium butyricum-alanine dehydrogenase-Micrococcus luteus ... Conversion of phenylpyruvate to l-phenylalanine by immobilized Clostridium butyricum-alanine dehydrogenase-Micrococcus luteus ...
Clostridium butyricum is a butyrate-producing bacteria that controls intestinal homeostasis and helps to prevent inflammation. ... Active ingredient: Enterococcus faecium, Clostridium butyricum, Bacillus subtilis. Medical effect: Bio-Three tablets are ... How effective are Bio-Three combination tablets from Japan for intestinal flora (probiotic, Enterococcus faecium, Clostridium ... butyricum, Bacillus subtilis)?. Bio-Three combination tablets contain three different probiotics that help to improve the ...
Clostridium butyricum combined with Bifidobacterium infantis), and the predominant bacteria (Clostridium cluster I and ... Effect of Additional Clostridium butyricum on the Intestinal Flora of Chronic Hepatitis B Patients Treated with Entecavir. ... 3 mo of probiotics 1500-mg TD, which contained Clostridium butyricum combined with Bifidobacterium infantis. Probiotics (n = 30 ... CHB: Chronic hepatitis B; CB: Clostridium butyricum; CRP: C-reactive protein; EcN: Escherichia coli Nissle 1917; ETV: Entecavir ...
2018). Necrotizing enterocolitis associated with Clostridium butyricum in a Japanese man. https://www.ncbi.nlm.nih.gov/pmc/ ...
10] Clostridium baratii and Clostridium butyricum also produce botulinum toxin. These organisms produce type E and F toxins. ... Identification of Clostridium botulinum and its toxins in faeces. Lancet. 1976 Oct 30. 2(7992):934-6. [QxMD MEDLINE Link]. ... Whether Clostridium argentinense is a subgroup of C botulinum or a separate species is currently under debate. ... Umeda K, Seto Y, Kohda T, Mukamoto M, Kozaki S. A novel multiplex PCR method for Clostridium botulinum neurotoxin type A gene ...
Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus,. Lactic acid bacillus. 1 capsule 3 times per day. ... Clostridium butyricum and Bifidobacterium infantis. Dose of 1500 mg, 3 times daily for 3 months containing more than 1.0 × 107 ... Using probiotics (a combination of Clostridium butyricum and Bifidobacterium infantis) in MHE reduced harmful Enterococcus and ... Lachnospiraceae and Clostridia XIV) and lowered the number of pathogenic bacteria (Enterobacteriaceae). This was also ...
... and Clostridium butyricum TO-A [38,39]. Both positive and negative effects were found in these trials, further confirming our ...
Fusobacteria, Bacteroidetes, and Clostridia were the most abundant bacteria in the EOCRC group, LOCRC group, and NC group, ... Fusobacteria, Bacteroidetes, and Clostridia were the most abundant bacteria in the EOCRC group, LOCRC group, and NC group, ... 2021). Butyrate-producing human gut symbiont, clostridium butyricum, and its role in health and disease. Gut Microbes 13 (1), 1 ... Zhou, M., Yuan, W., Yang, B., Pei, W., Ma, J., Feng, Q. (2022). Clostridium butyricum inhibits the progression of colorectal ...
Clostridium bifermentans. Clostridium butyricum. Clostridium cadaverum. Clostridium difficile. Clostridium fallax. Clostridium ...
Clostridium butyricum (Miyarisan and AOR-3 ). Culturelle Health and Wellness. Femdophilus Probiotics By Jarrow. Align Probiotic ... Miyarisan (clostridium butyricum from the study discussed above. Good for pregnant and breastfeeding mothers who are not ... AOR-3 (clostridium butyricum from the study discussed above. Good for pregnant and breastfeeding mothers who are not concerned ... Currently there are two probiotics available that have the clostridium butyricum probiotic from that study: AOR-3 and Miyarisan ...
The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open- ...
Clostridium novyi-NT was cultured from 1 of 6 tumors. Five dogs were available for response assessment (4 had stable disease; 1 ... Abstract Objective-To establish the maximum tolerated dose of Clostridium novyi-NT spores in tumor-bearing dogs and evaluate ... Oncolysis by clostridia. I. Activity of Clostridium butyricum (M-55) and other non-pathogenic clostridia against the Ehrlich ... Oncolysis by clostridia. I. Activity of Clostridium butyricum (M-55) and other non-pathogenic clostridia against the Ehrlich ...
... oral administration of Clostridium butyricum (C. butyricum) CGMCC0313.1 to nonobese diabetic mice resulted in a significant ... J. Zhang, H. Su, Q. Li et al., "Oral administration of Clostridium butyricum CGMCC0313-1 inhibits β-lactoglobulin-induced ... Z. Juan, S. Zhao-Ling, Z. Ming-Hua et al., "Oral administration of Clostridium butyricum CGMCC0313-1 reduces ovalbumin-induced ... L. Jia, K. Shan, L. L. Pan et al., "Clostridium butyricum CGMCC0313.1 protects against autoimmune diabetes by modulating ...
Dogs that ate a low-protein, high-carbohydrate diet had higher abundances of Bacteroides uniformis and Clostridium butyricum. ... They also reported that abundances of Clostridium hiranonis, Clostridium perfringens, and Ruminococcus gnavus were more than ...
Inhibition of growth of some enteropathogenic strains in mixed cultures of Streptococcus faecalis and Clostridium butyricum. ... Yet a combination of S. faecalis and C. butyricum resulted a stronger effect and growth of E. coli was not observed on agar ... butyricum, either separately or combined, inhibited E. coli growth at a ratio of 1/100-1/1000. ...
Kanai T, Mikami Y, Hayashi A. A breakthrough in probiotics: clostridium butyricum regulates gut homeostasis and anti- ...
... or by culturing botulinum neurotoxin-producing species of Clostridium (C. botulinum, C. butyricum, or C. baratii) from stool or ...
Genetic confirmation of identities of neurotoxigenic Clostridium baratii and Clostridium butyricum implicated as agents of ... Sugii S, Ohishi I, Sakaguchi G (1977) Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A ... Tsukamoto K, Kohda T, Mukamoto M, Takeuchi K, Ihara H, Saito M, Kozaki S (2005) Binding of Clostridium botulinum type C and D ... Oguma K, Inoue K, Fujinaga Y, Yokota K, Watanabe T, Ohyama T, Takeshi K, Inoue K (1999) Structure and function of Clostridium ...

No FAQ available that match "clostridium butyricum"

No images available that match "clostridium butyricum"